Immuno-PET Imaging of Siglec-15 Using the Zirconium-89-Labeled Therapeutic Antibody, NC318
Objective. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is overexpressed in various cancers which has led to the development of therapeutic anti-Siglec-15 monoconal antibodies (mAbs).
Elaine M. Jagoda +12 more
doaj +2 more sources
Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma [PDF]
BackgroundSialic acid-binding immunoglobulin-like lectin-15 (Siglec-15) was reported to be a novel immune checkpoint molecule comparable to programmed cell death 1 ligand 1 (PD-L1).
Quan Chen +9 more
doaj +2 more sources
Siglec-15 and its glycan ligands in tumor-associated macrophage biology and immunotherapy [PDF]
Siglec-15 has recently emerged as an important regulator at the interface of glyco-immunology and cancer-immunology. The transmembrane immune receptor links cancer-associated glycosylation to immune suppression in the tumor microenvironment (TME). Siglec-
Romana T Netea-Maier +6 more
doaj +2 more sources
Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis [PDF]
BackgroundSiglec-15 is expressed in a variety of cancers. However, the role of Siglec-15 in the prognosis of cancer patients remains controversial. Therefore, we conducted a meta-analysis to clarify the potential prognostic value of Siglec-15 in solid ...
Kui-Ying Jiang +5 more
doaj +2 more sources
Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b [PDF]
Sialic acid-binding Ig-like lectin 15 (Siglec-15) is an immune modulator and emerging cancer immunotherapy target. However, limited understanding of its structure and mechanism of action restrains the development of drug candidates that unleash its full ...
Maria Pia Lenza +21 more
doaj +2 more sources
Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma [PDF]
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) might be involved in the activation of important pathways related to tumor immune escape, along with programmed death-ligand 1 (PD-L1).
Ju Zhao +12 more
doaj +2 more sources
Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway [PDF]
Recurrence and metastasis are important features of osteosarcoma (OS) that cause its poor prognosis. Aberrant expression of Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been reported in various kinds of cancers.
Meng-ke Fan +8 more
doaj +2 more sources
Siglec-15-induced autophagy promotes invasion and metastasis of human osteosarcoma cells by activating the epithelial–mesenchymal transition and Beclin-1/ATG14 pathway [PDF]
Background Pulmonary metastasis is the main cause of poor prognosis in osteosarcoma. Sialic acid-bound immunoglobulin lectin 15 (Siglec-15) has been demonstrated to be obviously correlated with pulmonary metastasis in osteosarcoma patients.
Bingxin Zheng +10 more
doaj +2 more sources
Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes [PDF]
Siglecs are well known immunotherapeutic targets in cancer. Current checkpoint inhibitors have exhibited limited efficacy, prompting a need for novel therapeutics for targets such as Siglec-15. Presently, small molecule inhibitors targeting Siglec-15 are
Mohammed Saqif Ahmad +5 more
doaj +2 more sources
Prognostic significance of tumoral Siglec-15 expression in solid tumors: a systematic review and meta-analysis [PDF]
BackgroundSiglec-15 has emerged as a novel immune checkpoint molecule and a potential therapeutic target in solid tumors. Previous studies reported inconsistent prognostic significance of tumoral Siglec-15 expression across cancer types.
Ningning Zhang +4 more
doaj +2 more sources

